NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line:	RNJ19; congenital nephrotic syndrome mutation
NIH Registration Number:	0126
NIH Approval Number:	NIHhESC-11-0126
Available for Distribution:	Yes
Provider Restrictions:	No Restrictions
Additional Information:	This cell line was derived from an embryo that definitively carried the maternal mutation for congenital nephrotic syndrome; however, the status of the paternal mutation is unknown. The line could be either a compound heterozygote (positive for both the maternal and paternal mutations), or a simple heterozygote (positive for the maternal mutation and negative for the paternal mutation).
NIH Restrictions:	NIH-funded research with this line is limited to research consistent with the following language from the informed consent document: "...characterization of stem cells from embryos discarded due to genetic defects or other abnormalities and the development of new methods for transforming stem cells into other cell types."
Submitting Organization:	Reprogenetics, LLC
Provider Name:	Reprogenetics, LLC
Provider Phone:	9733225043
Provider Email:	mina.alikani@embryos.net
Provider URL:
Approval Date:	06/16/2011

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

hESC Line Listings:

NIH Form 2890:

Login Page
(Authorization Required)

Stem Cell Information:

NIH Stem Cell Information Page

RSS Feed:

RSS Data Feed

Contact Us:

Email questions to:
hescregistry@mail.nih.gov